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Abstract
Background: In Ehlers-Danlos syndrome (EDS), a group of 
monogenic disorders affecting connective tissues, obstruc-
tive sleep apnoea (OSA) is highly prevalent in adults. The 
prevalence of OSA in children with EDS is unknown. Objec-
tives: This prospective cross-sectional study aimed at deter-
mining the prevalence of OSA in paediatric EDS patients. 
Methods: Children with EDS (n = 24) were recruited from the 
Children’s Hospital Zurich and matched to healthy controls. 
Participants completed home respiratory polygraphy and 
questionnaires (Sleep-Related Breathing Disorder Scale 
[SRBD], Epworth Sleepiness Scale [ESS], and Child Health 
Questionnaire [CHQ]). The American Academy of Sleep Med-
icine criteria were applied for OSA diagnosis (obstructive ap-
noea-hypopnoea index [oAHI] ≥1/h). Conditional logistic re-
gression was used to compare the prevalence of OSA and to 
adjust for possible confounding. Results: OSA was found in 
42% of paediatric EDS patients and in 13% of matched con-
trols (OR = 4.5, 95% CI = 0.97–20.83, p = 0.054). The median 
oAHI was higher in EDS patients than in controls (0.77/h, 
IQR = 0.19–1.76, vs. 0.24/h, IQR = 0.0–0.60, p < 0.001 adjusted 
for age, sex, and BMI z-score). EDS patients had lower scores 
in most CHQ scales and higher SRBD and ESS scores than 
controls (0.26, IQR = 0.1–0.35, vs. 0.07, IQR = 0–0.19, p = 
0.004); 7 ± 4 vs. 5 ± 4, p = 0.033, respectively). Conclusion: 
OSA is a previously underestimated EDS-related complica-
tion increasing disease burden. © 2018 S. Karger AG, Basel
Introduction
Ehlers-Danlos syndrome (EDS), a group of monogen-
ic disorders affecting connective tissues, is recognized by 
its fragility of the soft connective tissue and its impact on 
skin, ligament, joints, blood vessels, and internal organs. 
With a prevalence of 1/5,000 in the general population, 
EDS classifies as an orphan disease. However, with in-
creasing medical awareness, underestimation of EDS 
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prevalence has been suggested [1, 2]. Although EDS clin-
ically manifests with symptoms such as hyperelastic skin, 
joint hypermobility resulting in luxation, joint effusions, 
abnormal wound healing and scaring, as well as easy 
bruising, its spectrum also includes unusual and yet most-
ly unexplained findings such as chronic fatigue and pain, 
besides neurophysiological and neurodevelopmental fea-
tures [1, 2]. Particularly, chronic fatigue occurs as fre-
quently as in 77% of EDS patients, resulting in a higher 
level of psychological distress [3]. Investigating this phe-
nomenon more closely, Gaisl et al. [4] found a higher 
prevalence of obstructive sleep apnoea (OSA) in adults 
with EDS compared to matched controls, and OSA was 
associated with fatigue and excessive daytime sleepiness 
in EDS patients.
In adults, the key symptom of OSA is excessive day-
time sleepiness, whereas in children and adolescents, be-
havioural and cognitive alterations such as hyperactivity 
and attention-deficit disorder are more frequent conse-
quences [5]. Untreated OSA in developing children is as-
sociated with poorer executive function, worse memory 
skills, and lower general intelligence, resulting in poor 
school performance and reduced quality of life [6–8]. 
Furthermore, children with severe OSA are at a higher 
risk of developing cardiovascular disease including sys-
temic hypertension, pulmonary hypertension, and cor 
pulmonale with heart failure [9–11]. Moreover, it has 
been observed that children with severe OSA are at risk 
of growing poorly and gaining less weight than healthy 
peers [12].
The estimated prevalence of paediatric OSA in the 
general population ranges from 2 to 10%, depending on 
the criteria of diagnosis [13–15]. The prevalence of OSA 
in children and adolescents with EDS, however, has not 
yet been assessed, despite multiple risk factors for OSA 
in these patients. Orofacial anatomic changes and mus-
cular hypotonia as well as abnormal growth of the naso-
maxillary complex often seen in EDS patients may lead 
to increased nasal resistance and altered maxillary devel-
opment [1, 16]. In addition, hyperplasia of the adenoton-
sillar tissue during preschool years may contribute to up-
per airway obstruction in these children [1, 9, 16]. There-
fore, we aimed to assess the prevalence of OSA and its 
possible association with symptoms and quality of life in 
children and adolescents with EDS. We hypothesized 
that OSA is more prevalent in EDS compared to healthy 
controls. The primary outcome was OSA diagnosed 
based on current recommendations [17]; the secondary 
outcomes were symptoms related to sleep-disordered 
breathing.
Methods
Subjects
This study was conducted as a prospective one-to-one-matched 
case-control study comparing children and adolescents with EDS 
with healthy controls. From April 2015 to December 2016, chil-
dren and adolescents with EDS (n = 33) aged from 6 to 18 years 
were recruited from the University Children’s Hospital Zurich 
during ambulatory visits in the Connective Tissue Unit of the Di-
vision of Metabolism and Children’s Research Centre and via an 
international network based on EDS associations and EDS support 
groups. Children and adolescents with EDS were eligible for enrol-
ment if they had a confirmed diagnosis of EDS according to the 
Villefranche diagnostic criteria [1] or, if applicable, objectively 
confirmed by gene analysis, pathological electron microscopic re-
sults, abnormal biochemical collagen findings, or altered urinary 
pyridinoline crosslink formation as previously reported by Gaisl et 
al. [4]. As the study was carried out between April 2015 and De-
cember 2016, EDS patients were not diagnosed according to the 
newest guidelines published in 2017, and nomenclature in this 
study was used accordingly [18]. EDS patients were matched to 
healthy controls one-to-one according to sex, age (±1.5 years), eth-
nicity, and nutritional status based on BMI z-score (severe thin-
ness, thinness, normal weight, overweight, and obesity [19]). Con-
trol subjects were recruited via online advertisements and leaflets 
without mentioning “sleep apnoea” or “sleep disturbances” to 
minimize possible selection bias. Exclusion criteria were continu-
ous positive airway pressure therapy, pregnancy, as well as physical 
and intellectual incapacity to adhere to the study protocol. More-
over, sleep studies were not conducted when children showed 
symptoms suggesting upper airway infections, allergic rhinitis, or 
topical nasal treatment.
Measurements
The main outcome of interest was the assessment of the OSA 
prevalence in children and adolescents with EDS. Other outcomes 
of interest were predictors of OSA and its impact on quality of life 
in children and adolescents with EDS.
After enrolment, parents completed a detailed questionnaire 
together with their child, including socioeconomic characteristics, 
ethnicity, relevant medical history regarding EDS, history of ade-
noidectomy or tonsillectomy, respiratory symptoms (rhinitis, 
cough), asthma, snoring status, cardiac disease, level of activity, 
and history of smoking and alcohol consumption. Additionally, 
data concerning participants’ parents’ history of adenoidectomy, 
OSA, and smoking habits (e.g., during pregnancy) were collected. 
The BMI z-score was computed using the QuesGen online calcula-
tor (http://www.quesgen.com/BMIPedsCalc.php). Neck circum-
ference, gauged at the most prominent part of the thyroid, and 
waist circumference, measured in the middle between the iliac 
crest and the lowest rib on the level of the navel, were either self-
measured as instructed or assessed by a physician (A.S.S.) [20]. 
Optionally, the participants’ tonsillar size and the visibility of ana-
tomical structures in the oropharynx was assessed and document-
ed using the Mallampati score and the Brodsky classification, re-
spectively.
All patients included in the study completed a respiratory 
polygraphy using an out-of-centre level 3 portable sleep test (Ap-
neaLink Air or Nox T3, both ResMed, San Diego, CA, USA). Sleep 
recordings always took place in the home environment to ensure 
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the child’s best quality of sleep, and recordings of paediatric EDS 
patients and their matched controls were always taken with the 
same type of device. OSA was diagnosed according to the scoring 
criteria of the American Academy of Sleep Medicine 2012 with an 
obstructive apnoea-hypopnoea index (oAHI) ≥1/h. OSA syn-
drome (OSAS) was defined as an oAHI ≥1/h plus symptoms sug-
gestive of sleep-disordered breathing. Standard paediatric scoring 
criteria were used for scoring respiratory events [17]. In particular, 
obstructive apnoea was scored if the peak signal excursion dropped 
by ≥90% of the baseline for at least two breaths in the presence of 
respiratory effort, and hypopnoea was scored if the peak signal ex-
cursion dropped by ≥30% for at least two breaths with a desatura-
tion of ≥3% [17]. All sleep studies were reviewed manually by a 
trained investigator (A.S.S.) and checked by a clinical sleep expert 
(A.M.). The investigators were blinded with regard to EDS status 
and results of the questionnaires.
Parents completed validated questionnaires for breathing dis-
orders during sleep utilizing the Sleep-Related Breathing Disorder 
Scale (SRBD), daytime sleepiness utilizing the Epworth Sleepiness 
Scale (ESS), and quality of life utilizing the Child Health Question-
naire (CHQ) with their children.
Statistical Methods
All data was analysed with Stata version 14 (StataCorp LP, Col-
lege Station, TX, USA). Results are shown as mean (standard de-
viation) or median and quartiles as appropriate. A two-sided p 
value < 0.05 was considered statistically significant.
To compare the prevalence of OSA between children and ado-
lescents with EDS and controls, conditional logistic regression was 
used, adjusting for possibly confounding variables (age, sex, and 
BMI z-score). For comparison of respiratory events, mixed-effects 
linear regression was applied, adjusting for the confounding vari-
ables and accounting for the cluster of each one-to-one-matched 
EDS-control pair as a random effect. For analysis of the CHQ, 
mixed-effects linear regression was calculated in pairs, and for 
analysis of predictors unadjusted linear regression was used.
Results
Participants
Of 49 identified paediatric EDS patients, 33 could be 
included in the study. Nine patients dropped out of the 
study, thus the data of 24 paediatric EDS patients 
matched one-to-one to 24 healthy controls entered the 
final analysis. The EDS diagnosis was confirmed in all 
paediatric EDS patients as mentioned in the Methods 
section, and none of the patients was newly diagnosed 
due to study participation. The baseline characteristics 
of paediatric EDS patients and healthy controls are 
shown in Table 1, and additional background informa-
tion regarding EDS subtypes, criteria of diagnostic con-
firmation, medical centres for diagnosis, and countries 
of origin of paediatric EDS patients can be found in on-
line supplementary Tables 1–4 (for all online suppl. ma-
terial, see www.karger.com/doi/10.1159/000494328).
Prevalence of OSA
OSA was found to be highly prevalent in paediatric 
EDS patients with 42 vs. 13% in controls with an OR of 
4.5 (95% CI = 0.97–20.83, p = 0.054). Moreover, in the 
adjusted analysis for the confounding variables (age, sex, 
and BMI z-score), a significantly higher prevalence of 
OSA as well as OSAS was seen in paediatric EDS patients. 
Furthermore, the sleep study data showed a statistically 
significantly higher median oAHI in paediatric EDS pa-
tients than in controls (Table 2; Fig. 1). Obstructive ap-
noeas and hypopnoeas were more often found in the EDS 
Table 1. Baseline characteristics of participants in each group
EDS 
(n = 24)
Controls 
(n = 24)
Female sex 16 (66.7%) 16 (66.7%)
Caucasian ethnicity 23 (95.8%) 23 (95.8%)
Age, years 14.2 (10.7–15.3) 13.9 (10.7–15.9)
BMI z-score –0.55±1.1 –0.24±1.0
Neck circumference, cm 30.7±3.1 30.9±2.6
Waist circumference, cm 68.1±7.7 69.9±8.9
Neck-to-waist ratio 0.46±0.0 0.44±0.0
Values are presented as n (%), median (IQR), or mean ± SD. 
EDS patients and controls were matched one-to-one for sex, age, 
category of BMI z-score, ethnicity, and sleep monitoring device. 
BMI, body mass index; EDS, Ehlers-Danlos syndrome.
3.0
2.5
2.0
1.5
1.0
0.5
0
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HI
, e
ve
nt
s/h
EDS Controls
Fig. 1. Distribution of oAHI in paediatric EDS patients and con-
trols. The dashed line indicates the threshold for OSA (oAHI ≥1). 
The median (IQR) oAHI was higher in the EDS group (0.77 [0.19–
1.76]) than in the control group (0.24 [0.00–0.60]), with p < 0.001. 
EDS, Ehlers-Danlos syndrome; oAHI, obstructive apnoea-hypo-
pnoea index; OSA, obstructive sleep apnoea.
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group, whereas central apnoeas occurred similarly often 
in both groups. Additionally, no differences between 
groups were found regarding snoring events, mean night-
ly heart rate, and mean and minimal oxygen saturation. 
The complete analysed sleep study data can be found in 
Table 2. Subgroup analysis showed no differences in the 
frequency of OSA between different types of EDS (95% 
CI = –0.30–2.44, p = 0.119) (online suppl. Table 5; Fig. 2).
Daytime sleepiness measured by ESS and sleep-related 
breathing disorders measured by the SRBD were signifi-
cantly higher in the EDS group, and an unadjusted analy-
sis showed a modest correlation between a higher oAHI 
and a higher ESS score (r = 0.317, 95% CI = 0.00–0.11, 
p = 0.039).
Quality of Life
Children and adolescents with EDS had significantly 
lower scores in most CHQ scales than controls (p < 0.05), 
except for the behaviour categories, mental health, paren-
tal impact – time, and family cohesion (Table 3; Fig. 3). 
Generally, a higher oAHI was associated with a lower 
general health perception (r = –0.357, 95% CI = –0.02 to 
14
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Hypermobile
type (III)
Vascular
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type (VI)
Arthrochalasis
type (VII)
■ OSA
■ No OSA
Table 2. Sleep study data for paediatric EDS patients and controls
EDS (n = 24) Controls (n = 24) p value 95% CI
OSA (oAHI ≥1) 10 (41.7%) 3 (12.5%) 0.011 0.07–0.56
OSAS 4 (16.7%) 0 (0%) 0.025 0.02–0.33
oAHI, h 0.77 (0.19–1.76) 0.24 (0.00–0.60) <0.001 0.40–1.28
Obstructive apnoeas, events/h 0.30 (0.13–1.00) 0.00 (0.00–0.26) 0.002 0.18–0.81
Central apnoeas, events/h 0.59 (0.20–1.15) 0.31 (0.00–0.69) 0.119 –0.08–0.69
Hypopnoeas, events/h 0.32 (0.00–0.71) 0.00 (0.00–0.21) 0.009 0.09–0.61
Oxygen desaturation index, h (3%) 1.15 (0.65–2.20) 0.25 (0.00–0.60) <0.001 0.51–1.47
SpO2, % 95±1 95±1 0.914 –0.74–0.83
Minimal SpO2, % 90 (83–92) 90 (86–93) 0.369 –6.07–2.26
Snoring events/h 5.62 (3.63–17.51) 6.20 (3.72–10.23) 0.137 –1.48–10.79
Nightly heart rate, bpm 68±9 68±7 0.716 –5.03–3.45
ESS score 7±4a 5±4 0.033 0.22–5.31
SRBD score 0.26 (0.1–0.35)a 0.07 (0–0.19) 0.004 0.04–0.21
Values are presented as n (%), median (IQR), or mean ± SD. All analyses were adjusted for age, sex, and BMI z-score. EDS, Ehlers-
Danlos syndrome; ESS, Epworth Sleepiness Scale; oAHI, obstructive apnoea-hypopnoea index; OSA, obstructive sleep apnoea; OSAS, 
obstructive sleep apnoea syndrome; SpO2, oxygen saturation; SRBD, Sleep-Related Breathing Disorder Scale. a n = 20.
Fig. 2. Distribution of the frequency of 
OSA diagnosis by EDS subtypes in total 
numbers. EDS, Ehlers-Danlos syndrome; 
OSA, obstructive sleep apnoea.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
E-
M
ed
ie
n 
   
   
   
   
   
   
   
   
 
14
4.
20
0.
17
.4
2 
- 1
/4
/2
01
9 
9:
03
:5
3 
AM
OSA in Children and Adolescents with 
Ehlers-Danlos Syndrome
5Respiration
DOI: 10.1159/000494328
–0.00, p = 0.017) and lower scores in the categories phys-
ical functioning (r = –0.381, 95% CI = –0.02 to –0.00, p = 
0.011) and both emotional (r = –0.314, 95% CI = –0.02 to 
–0.00, p = 0.038) and physical social limitations (r = 
–0.411, 95% CI = –0.02 to –0.00, p = 0.006). OSA diagno-
sis correlated with lower physical functioning (r = –0.334, 
95% CI = –0.01 to –0.00, p = 0.027).
Predictors of OSA
Potential predictors of a high oAHI in children and 
adolescents with EDS were investigated (Table 4). BMI 
z-score, neck-to-waist ratio, snoring history, history of 
tonsillectomy or adenectomy, or asthma did not predict 
OSA. In the unadjusted model, younger age correlated 
with a higher oAHI (p = 0.030). However, after adjusting 
the model for other potential predictive factors, age was 
no longer independently associated with oAHI.
Discussion
This was the first study to investigate the prevalence of 
OSA, its predictors, and its impact on quality of life in 
paediatric EDS patients. We found a substantially higher 
frequency of OSA and OSAS in children and adolescents 
with EDS in comparison to healthy matched controls. 
OSA diagnosis was associated with impaired quality of 
CH
Q 
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, p
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GGH PF REB RP BP
CHQ scales
BE GBE MH SE GH PE PT FA FC
100
80
60
40 EDSControls
Table 3. Detailed CHQ results
CHQ scales EDS 
(n = 20)a
Controls 
(n = 20)
95% CI p value
Global General Health 65.5±24.9 86.5±18.1 –34.46 to –7.54 0.020
Physical Functioning 57.8±36.7 98.3±7.5 –56.69 to –24.42 <0.001
Social Limitations – Emotional/Behavioural 73.3±35.2 95.0±22.4 –39.57 to –3.76 0.018
Social Limitations – Physical 61.7±37.9 100±0 –54.94 to –21.73 <0.001
Bodily Pain 49.0±31.4 76.0±19.0 –41.85 to –12.15 <0.001
Behaviour 69.6±16.9 72.5±18.5 –12.7 to 6.96 0.567
Global Behaviour Item 78.5±14.9 85.0±17.5 –14.52 to 1.52 0.112
Mental Health 70.8±22.7 77.1±15.0 –17.67 to 5.17 0.283
Self-Esteem 67.9±28.9 86.3±19.0 –34.43 to –2.23 0.026
General Health Perceptions 51.1±27.6 84.4±18.3 –49.52 to –17.23 <0.001
Change in Health 2.6±0.6 3.35±0.6 –0.35 to 3.61 <0.001
Parental Impact – Emotional 63.1±26.7 83.1±14.2 –32.49 to –7.51 0.002
Parental Impact – Time 71.7±30.2 82.5±27.3 –30.42 to 8.75 0.278
Family Activities 75.0±29.0 97.5±7.7 –36.11 to –8.89 0.001
Family Cohesion 68.3±13.3 72.3±20.0 –13.42 to 5.42 0.405
Values are presented as mean ± SD. CHQ, Child Health Questionnaire; EDS, Ehlers-Danlos syndrome. a 20 EDS patients completed 
the validated CHQ questionnaire with their parents; analyses were calculated in matched pairs.
Fig. 3. Differences in the median scores of the CHQ between chil-
dren and adolescents with EDS and controls. The maximum ac-
quirable score is 100 in each scale, except for Change in Health, 
which was excluded from the graph due to its categorical values 
(2.6 ± 0.6 vs. 3.35 ± 0.6). The scales are as follows: GGH, Glo- 
bal General Health; PF, Physical Functioning; REB, Social Limita-
tions – Emotional/Behavioural; RP, Social Limitations – Physical; 
BP, Bodily Pain; BE, Behaviour; GBE, Global Behaviour Item; MH, 
Mental Health; SE, Self-Esteem; GH, General Health Perceptions; 
PE, Parental Impact – Emotional; PT, Parental Impact – Time; FA, 
Family Activities; FC, Family Cohesion. CHQ, Child Health Ques-
tionnaire; EDS, Ehlers-Danlos syndrome.
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life and lower physical functioning. Our study reveals that 
OSA and OSAS have previously been underestimated as 
an EDS-related complication that significantly increases 
disease burden.
In the present study, we observed that 42% of paediat-
ric EDS patients suffered from OSA and 17% from OSAS. 
In comparison to adult EDS patients, the prevalence of 
OSA in children was considerably higher, but OSAS was 
less often observed; in 34% of adults with EDS OSA was 
diagnosed, and 23% suffered from OSAS [4]. Compared 
to adults with EDS, this may be related to poor symptom 
perception in both children and parents. Moreover, in 
our study, the prevalence of OSA in children and adoles-
cents with EDS was substantially higher than in matched 
controls (13%). Similar to our findings, a study from the 
US observed an oAHI ≥1 in 10.8% of children aged 8–11 
years [21]. In comparison to other diseases associated 
with a high OSA prevalence in children, it is notable that 
the prevalence of OSA in children and adolescents with 
EDS was found to be even higher than in children and 
adolescents with e.g. cleft palate (8.5% with an oAHI ≥1) 
[22], but lower than in children with Pierre Robin syn-
drome (85% with a oAHI ≥1) or Down syndrome (73% 
with an oAHI ≥1) [23, 24]. In contrast to children suffer-
ing from these pathologies, in EDS patients craniofacial 
abnormalities are not risk factors for OSA [4]. Geneti-
cally related cartilage defects and tissue flaccidity that in-
creases the pharyngeal collapsibility, on the other hand, 
are specific for EDS and suspected to cause OSA [16, 25].
Awareness about the high prevalence of OSA in chil-
dren and adolescents with EDS is important in the clinical 
setting. The diagnosis of sleep disorders through sleep 
studies is costly and often cumbersome, especially for 
young children. Therefore, the identification of potential 
predictors would be of great help for assessing possible 
OSA and the need for a sleep study. In the general popu-
lation, shifts in the risk factors for OSA occur from child-
hood through adolescence [21]. While in childhood small 
airway size and enlarged lymphoid tissue increase the 
risk, in adolescence obesity and male sex are associated 
with OSA [26]. However, in our study population, chil-
dren and adolescents were thin with a mean BMI z-score 
of –0.55, which is considered a low normal nutritional 
status, and predominantly female (67%), which is consis-
tent with proportions reported by other EDS studies [4]. 
Nevertheless, tonsillar hypertrophy being more frequent 
in younger children, this might explain why younger chil-
dren were at higher risk of developing OSA than adoles-
cents in our study. Nonetheless, we could not find a rela-
tionship between history of tonsillectomy or adenectomy 
and a higher oAHI in the EDS group.
In our study population, 50% (n = 12) of EDS patients 
suffered from the hypermobile EDS subtype (EDS-HT), 
and 6 patients with this subtype were diagnosed clini-
Table 4. Unadjusted analysis of predictors of a higher oAHI in EDS patients
Unadjusted Adjusteda
95% CI p value 95% CI p value
n = 24
Female sex 16 (66%) –1.61 to 0.18 0.110 –2.39 to 1.06 0.381
Age, years 14.2 (10.7–15.3) –0.26 to –0.01 0.030 –0.28 to 0.29 0.977
BMI z-score –0.55±1.1 –0.12 to 0.68 0.159 –1.15 to 0.85 0.725
Neck-to-waist ratio 0.46±0.0 –29.26 to 4.58 0.142 –31.41 to 18.59 0.553
Asthma diagnosis 5 (20.8%) –1.68 to 0.45 0.246 –1.39 to 2.18 0.608
n = 20
Snoring history 9 (45%) –0.65 to 1.18 0.555 –1.50 to 1.46 0.972
History of tonsillectomy/adenectomy 1 (5%) –2.93 to 1.20 0.390 –3.29 to 1.93 0.549
Exposure to cigarettes at home 0 (0%) – –
Prenatal cigarette exposure 0 (0%) – –
OSA diagnosis in parentsb 3 (16.7%) –0.05 to 2.28 0.060 –1.45 to 4.04 0.294
Values are presented as n (%), median (IQR), or mean ± SD. Bold indicates statistical significance (p < 0.05). 
BMI, body mass index; EDS, Ehlers-Danlos syndrome; oAHI, obstructive apnoea-hypopnoea index; OSA, 
obstructive sleep apnoea. a Adjusted for sex, age, BMI z-score, neck-to-waist ratio, diagnosis of asthma, history 
of tonsillectomy or adenectomy, and OSA diagnosis in parents. R2 = 0.6110. b n = 18.
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cally by the Villefranche criteria. EDS-HT and joint hy-
permobility syndrome, a disorder with hypermobility, 
laxity, and instability of the joints, are clinically very sim-
ilar [27]. EDS patients as well as joint hypermobility syn-
drome patients suffer frequently from fatigue [3, 28]. Yet, 
our study was underpowered for subgroup analysis. Fa-
tigue, on the other hand, is known to contribute to im-
paired quality of life [28]. In our study, children and ad-
olescents with EDS were found to suffer more often from 
daytime sleepiness and sleep-related breathing disorders 
than their control peers. Furthermore, daytime sleepi-
ness was associated with a lower general health percep-
tion and social limitations due to physical health prob-
lems in the CHQ score. Similarly, in adolescents with 
joint hypermobility syndrome aged 12–18 years, correla-
tions between increased general fatigue and emotional 
and social function impairment were found [29]. In our 
study, OSA had an impact on children and adolescents 
in general, as participants diagnosed with OSA presented 
with lower scores in physical functioning and a higher 
oAHI correlated with lower general health perception 
and emotional and physical social limitations. It is re-
markable that both increased daytime sleepiness in pae-
diatric EDS patients and diagnosis of OSA in the total 
study population were associated with lower scores in 
general health perception. Increased daytime sleepiness 
and higher oAHI were associated with social limitations 
due to physical health problems. Further and larger stud-
ies are needed to confirm the impact of OSA on overall 
health in paediatric EDS patients.
Some limitations of our study should be mentioned. 
We did not use polysomnography for the assessment of 
childhood OSA, but used respiratory polygraphy. There-
by, we were unable to assess sleep stages, and there is the 
possibility of an underestimation of the amount of sleep-
disordered breathing [30]. However, sleep monitoring at 
home may be more representative, as children’s sleep in 
a hospital environment was reported to be atypical in 
one-third of patients [31]. Moreover, the used sleep mon-
itoring devices ApneaLink Air and Nox T3 demonstrated 
good diagnostic performances in comparison to poly-
somnography in several studies [32, 33].
Conclusion
The results of our study demonstrate that there is a 
high prevalence of OSA(S) in children and adolescents 
with EDS. Moreover, daytime sleepiness – one of the ma-
jor symptoms in adult EDS patients – and hyperactivity 
were also found to be a problem in children and adoles-
cents with EDS. To assess whether treatment of OSA also 
improves these symptoms, further studies are needed.
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